Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection - Wikidata - wikimedia - TriplyDB

Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection

Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection

http://www.wikidata.org/entity/Q37247875

about

Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?Antibodies for prevention of mother-to-child transmission of HIV-1 Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk.Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?

P2860

Q27008774-6E64D0B6-C092-4C33-8AD4-A9AA85D92ABE Q35619402-0E35F5A4-BFB0-4D63-846B-2941F7D21572 Q36184762-6031DAF2-377A-4668-9868-DE6DDB6E5BDF Q36548276-A2679702-D17A-4282-BEB9-2C8BA9352D61 Q37365618-57FB6EB1-9072-4B13-8F3A-13CB36439A27 Q37488218-800DAF38-5EB4-486E-8A59-43B2B962AAAA Q38621582-E8E2565B-C1B9-42CD-9694-F1EAD8E7BEA4 Q40331385-A4A71B28-51E5-4A86-9D7B-8E237E95909B Q41471213-65F46A52-95EF-4BC0-B31E-EF02A1453E44 Q42638889-43D0EEEB-FAA3-4A38-BFDA-B1923B046096 Q56974226-4484D378-9265-42A4-937D-3582E000E9D9

P2860

Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection

http://www.wikidata.org/entity/Q37247875

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evidence for efficient vertica ...... with reduced infant infection

@en

Evidence for efficient vertica ...... with reduced infant infection.

@nl

type

label

Evidence for efficient vertica ...... with reduced infant infection

@en

Evidence for efficient vertica ...... with reduced infant infection.

@nl

prefLabel

Evidence for efficient vertica ...... with reduced infant infection

@en

Evidence for efficient vertica ...... with reduced infant infection.

@nl

P1433

Q37247875-B26BC388-EB29-44EB-814E-94218372AFF9

P1476

Q37247875-F5AD8479-0464-42BA-9119-8AD3C0B41CEA

P2093

Q37247875-1B44645B-88D1-4F12-B3E2-35541EFD242D

Q37247875-3ACEC593-8EF0-4058-A7F8-E938A0ACEB1D

Q37247875-865C3243-C8FC-4396-8DAA-A758F424060F

Q37247875-A1BE2093-76D9-416C-B7B0-8793427391B0

P2860

Q37247875-1B70B56D-4F60-42B9-9B7D-1A4AE7C91587

Q37247875-24D058C2-F172-437C-9E5C-4767540877E1

Q37247875-3E9F5154-6332-429E-87F4-EA7BB1BB3050

Q37247875-69D13C21-6C13-4F74-B661-88CA044E0128

Q37247875-891F77E3-A46D-4BED-B088-AD2BB24AC443

Q37247875-9A3668DC-240C-42C7-853A-152BD0DD929C

Q37247875-B8F0DF08-A821-4A1D-958A-379436973622

Q37247875-BCB3D575-2E52-4E9A-BCBD-8E02BED5264D

Q37247875-C5F85547-2D07-4B56-9C23-525A96C7119C

Q37247875-CF8AAAC6-09AA-4DBA-B21F-F057B98BCCA8

P304

Q37247875-A052B65A-4AB3-4A2F-BB45-5C423365DBCB

P31

Q37247875-578729AC-35CF-479A-BF50-85CF4124679E

P356

Q37247875-46D2D348-72D8-4BD5-AA21-0A9A368C70E6

P407

Q37247875-72B7A9F7-2828-4467-8A30-C5257B777AD6

P433

Q37247875-2161CE7D-4D6D-4195-BE12-85A5C280B96A

P478

Q37247875-0093A63B-A568-474D-A38E-DC0BCD228484

P50

Q37247875-35C2222C-48D6-49A8-AC15-49E629D8D509

Q37247875-4E3E8C95-0C0C-460E-8E71-C593B4B5EF17

Q37247875-CAA44066-169F-4B09-9D69-DDBD27C43FCE

Q37247875-D89C7D37-F53D-4A25-8569-EA9764BACDE7

P577

Q37247875-B9073DAE-ABAD-4E17-A6BE-D59ECC1B4911

P698

Q37247875-6B90CE8C-7813-4088-8082-B72A4D9ED508

P921

Q37247875-B279A912-4AFB-405F-98A5-0793C03FEFE3

P932

Q37247875-84717481-1334-4DC2-8791-57B52532CD9D

P356

QAI.0B013E31829F6E41

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Evidence for efficient vertica ...... with reduced infant infection

@en

P2093

Caitlin Milligan

http://www.w3.org/2001/XMLSchema#string

John Lynch

http://www.w3.org/2001/XMLSchema#string

Katherine Odem-Davis

http://www.w3.org/2001/XMLSchema#string

Maxwel M Omenda

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya

Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant

Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.

The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.

Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3

Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission

Cross-reactive broadly neutralizing antibodies: timing is everything.

Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.

P304

163-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E31829F6E41

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Grace John-Stewart

Julie Overbaugh

Barbra A Richardson

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23774880

http://www.w3.org/2001/XMLSchema#string

P921

P932

3805370

http://www.w3.org/2001/XMLSchema#string